Saturday, December 21, 2024
HomeAdvertiser FeaturesBlood and Marrow Transplant Program one of the best in the United...

Blood and Marrow Transplant Program one of the best in the United States

Zaid Al-Kadhimi, MD, Director of Bone Marrow Transplant and Cellular Therapy, Associate Professor, Internal Medicine, Division of Oncology & Hematology

The Nebraska Medicine Blood and Marrow Transplant (BMT) Program at the Fred & Pamela Buffett Cancer Center is one of the top programs of its kind in the United States. Our team of 12 hematologists includes national and international experts in lymphoma, leukemia, MDS, myelofibrosis and multiple myeloma.

These physicians specialize in BMT and CAR T-cell therapy research. Since the
1980s, the program has pioneered several methods of stem cell mobilization, which
eventually became national standards. We perform about 180 transplants per
year and more than 5,000 patients have been treated from all 50 states and various
countries around the world.

The scientific mission for the program is to develop transplant platforms with minimal physical and immunologic toxicity and a focus on enhancing anti-tumor immune response post-transplant. One of the differentiators of the Fred & Pamela Buffett Cancer Center is the integration of scientists and clinicians, which provides them with the opportunity to work together in the evaluation of our cancer patients to design new treatments. Doctors and researchers work in the same building. As an NCI-designated cancer center, we perform many clinical trials for patients with hematologic malignancies pre- and post-transplant, which provides us access to cutting edge therapy options for our patients.

To provide each person who needs a transplant with the best care possible, our highly skilled transplant doctors, nurses, nurse practitioners and pharmacists work collaboratively with a team of experts that includes radiation oncologists, immunologists, gastroenterologists, kidney specialists, radiologists, psychiatrists, psychologists, physical and occupational therapists and social workers.

An example of medical advancement made possible by our kidney and bone marrow transplant teams is their collaboration on a phase 3 clinical trial to overcome kidney rejection by transplanting a living kidney donor’s stem cells into the recipient shortly after the kidney is transplanted.

  • For more information, please contact the office of International Healthcare Services at Nebraska Medicine: oihs@nebraskamed.com

- Advertisment -

Most Popular